Palomar Icon Aesthetic System

K142376 · Cynosure, Inc. · GEX · Sep 24, 2014 · General, Plastic Surgery

Device Facts

• Record ID: K142376
• Device Name: Palomar Icon Aesthetic System
• Applicant: Cynosure, Inc.
• Product Code: GEX · General, Plastic Surgery
• Decision Date: Sep 24, 2014
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions. The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The 1540 Fractional Non-ablative Laser Handpiece is intended for use in the coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures. The 1540 Fractional Non-ablative Laser and 2940 Fractional Abaltive Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrides, furrows, fine lines, textural irregularities, dyschromia and pigmend lesions. The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularties, dyschromia and pigmented lesions. The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications. In addition, it is intended to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of may also help muscle spasms, minor sprains and strains, and minor muscular back pain. The 1064 Laser Handpiece is intended for the removal of unwanted hair for skin types I-VI, and to effect stable long-term permanent hair reduction; treatment of benign pigmented lesions such as, but not limited to, senile lentigines (age spots), solar lentigos (sun spots), pigmented seratosis; tattoos (significant reduction in the intensity of black and/or blue-black tattoos); pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser/light treatment of vascular lesions such as but not limited to, port wine stains, hemangiomas, telangiectasias, rosacea, venus lake, facial and leg veins; reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar; coagulation and hemostasis of soft tissue; treatment of wrinkles and pseudofolliculitis barbae (FFB). The Max series Intense Pulsed Light Handpieces are intended for the treatment of inflammatory acne (acne vulgaris) and for the treatment of benign pigmented epidermal and cutaneous lesions, including warts, scars and striae, removal of unwanted hair from skin types I-VI, and to effect stable long-term, or permanent, hair reduction; treatment of benign pigmented lesions, including port wine stains, hemangiomas, aniomas, telangiectasias, rosacea, facial and leg veins. The Skintel Reader is intended as an objective measurement tool for examining skin melanin content for determining and setting a test spot starting fluence.

Device Story

Palomar Icon Aesthetic System delivers broadband incoherent or laser light to target sites via interchangeable handpieces. System comprises stacking modules: power supply, control electronics, chiller, heat exchanger, base module, remote interlock, emergency-off, footswitch, and front panel monitor. Operated by clinicians in clinical settings. Handpieces provide specific wavelengths or IPL ranges for dermatological/surgical applications. Skintel Reader provides objective melanin measurement to determine starting fluence. Output is light energy for tissue ablation, coagulation, or heating. Benefits include skin resurfacing, hair reduction, lesion treatment, and pain relief. Device uses footswitch for activation.

Clinical Evidence

Bench testing only. Autoclave sterilization validation performed on 10x10 and 6x6 Focal Guide Assemblies. Testing confirmed no growth of G. stearothermophilus after 3 half-cycle rounds, meeting SAL ≤10^-6. Functional testing verified sterilization process does not impact device performance.

Technological Characteristics

System includes power supply, control electronics, chiller, heat exchanger, and interchangeable handpieces. Laser types include Er:YAG (2940 nm). Delivery via microlens array (fractional) or flatbeam. Connectivity includes remote interlock. Sterilization: Autoclave (steam) for Focal Guide Assemblies. Software: Control electronics for energy delivery.

Indications for Use

Indicated for patients requiring soft tissue surgical/dermatological procedures including skin resurfacing, wrinkle treatment, scar revision, hair removal (skin types I-VI), vascular/pigmented lesion treatment, and temporary relief of minor muscle/joint pain. Contraindications not explicitly listed.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Palomar Icon Aesthetic System (K110907)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized depiction of three human profiles facing right, arranged in a stacked formation. The profiles are rendered in black and have a flowing, interconnected design. The seal is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement. The text is also in black and is evenly spaced around the perimeter of the seal.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 24, 2014

Cynosure Incorporated Ms. Allyson Connor Regulatory Affairs Specialist 5 Carlisle Road Westford, Massachusetts 01886

Re: K142376

Trade/Device Name: Palomar Icon Aesthetic System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: ONG, GEX Dated: August 25, 2014 Received: August 26, 2014

Dear Ms. Connor:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

{1}------------------------------------------------

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

for

Sincerely yours,

# David Krause -S

- Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K142376

Device Name Palomar Icon Aesthetic System

### Indications for Use (Describe)

Indications for Use (Describe)

The 2940 Ablative Laser Handpiece is intended for use in surgical applications requiring the excision, incision, vaporization, and coagulation of soft tissue. Soft tissue includes skin, cutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, anal tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions.

The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia.

The 1540 Fractional Non-ablative Laser Handpiece is intended for use in the coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars.

The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures.

The 1540 Fractional Non-ablative Laser and 2940 Fractional Abaltive Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrides, furrows, fine lines, textural irregularities, dyschromia and pigmend lesions.

The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularties, dyschromia and pigmented lesions.

The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications. In addition, it is intended to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of may also help muscle spasms, minor sprains and strains, and minor muscular back pain.

The 1064 Laser Handpiece is intended for the removal of unwanted hair for skin types I-VI, and to effect stable long-term permanent hair reduction; treatment of benign pigmented lesions such as, but not limited to, senile lentigines (age spots), solar lentigos (sun spots), pigmented seratosis; tattoos (significant reduction in the intensity of black and/or blue-black tattoos); pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser/light treatment of vascular lesions such as but not limited to, port wine stains, hemangiomas, telangiectasias, rosacea, venus lake, facial and leg veins; reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar; coagulation and hemostasis of soft tissue; treatment of wrinkles and pseudofolliculitis barbae (FFB).

The Max series Intense Pulsed Light Handpieces are intended for the treatment of inflammatory acne (acne vulgaris) and FORM FDA 3881 (1/14) Page 2 of 2

for the treatment of benign pigmented epidermal and cutaneous lesions, including warts, scars and striae, removal of unwanted hair from skin types I-VI, and to effect stable long-term, or permanent, hair reduction; treatment of benign pigmented lesions, including port wine stains, hemangiomas, aniomas, telangiectasias, rosacea, facial and leg veins. The Skintel Reader is intended as an objective measurement tool for examining skin melanin content for determining and setting a test spot starting fluence.

{3}------------------------------------------------

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

# PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON A SEPARATE PAGE IF NEEDED.

#### FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

# 510(k) Summary:

A summary of 510(k) safety and effectiveness information in accordance with the requirements of 21 C.F.R. 807.92.

| 807.92(a)(1) - Submitter Information | |
|--------------------------------------|---------------------------------------|
| Name | Cynosure Inc. |
| Address | 5 Carlisle Road<br>Westford, MA 01886 |
| Name of contact person | Allyson Connor |
| Telephone | 978-367-8736 |
| Fax number | 978-256-6556 |
| Email | [e-mail] |
| Establishment Registration Number | 1222993 |
| Date prepared | 8/25/14 |
| 807.92(a)(2) - Name of device | |
| Trade or proprietary name | Palomar Icon® Aesthetic System |
| Common or usual name | Light and Laser System |
| Classification name | Instrument, Surgical, Powered, laser |
| Classification panel | General and Plastic Surgery |
| Regulation | 878.4810 |
| Product Code(s) | GEX, ONG |

# 807.92(a)(3) - Legally marketed device(s) to which equivalence is claimed

Palomar Icon® Aesthetic System, K110907

# 807.92(a)(4) - Device description

The Palomar Icon® Aesthetic System including attachable treatment handpieces is designed to deliver pulses of broadband incoherent or laser light to a predetermined target site. The Palomar Icon® Aesthetic System consists of three stacking modules that contain an internal power supply, control electronics, Chiller Module, Heat Exchanger Module, Base Module, remote interlock, emergency-off button, footswitch, power control, and front panel monitor with indicators. They system includes multiple treatment hadnpieces attached to the Base Module. Each Handpiece provides laser energy at a specific wavelength or Intense Pulsed Light (IPL) at a specific range.

## 807.92(a)(5) Intended use of the device

# Indications for use

The 2940 Ablative Laser Handpiece is intended for use in surgical applications

requiring the excision, incision, ablation, vaporization, and coagulation of soft tissue includes skin, cutaneous tissue, subcutaneous tissue, striated and smooth

tissue, muscle, cartilage meniscus, calculi or fragments, mucous membrane, lymph vessels and nodes, organs, and glands in the following indications: skin resurfacing, treatment of wrinkles, epidermal nevi, telangiectasia, spider veins, actinic chelitis, keloids, verrucae, skin tags, keratoses, scar revision (including acne scars), debulking benign tumors, debulking cysts and superficial skin lesions.

The 2940 Fractional Ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia.

{5}------------------------------------------------

The 1540 Fractional Non-ablative Laser Handpiece is intended for use in the coagulation of soft tissue. skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars.

The 1440 Fractional Non-ablative Laser Handpiece is intended for use in dermatological procedures requiring coagulation of soft tissue and skin resurfacing procedures.

The 1540 Fractional Non-ablative Laser and 2940 Fractional Abaltive Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions.

The 1440 Fractional Non-ablative Laser Handpiece and 2940 Fractional Ablative Laser Handpiece combined treatment is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularties, dyschromia and pigmented lesions.

The MaxIR Handpiece is intended for photocoagulation of soft tissue in dermatologic applications. In addition, it is intended to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles. In addition, it may also help muscle spasms, minor sprains and strains, and minor muscular back pain.

The 1064 Laser Handpiece is intended for the removal of unwanted hair for skin types I-VI, and to effect stable long-term permanent hair reduction; treatment of benign pigmented lesions such as, but not limited to, senile lentigines (age spots), solar lentigos (sun spots), pigmented seborrheic keratosis; tattoos (significant reduction in the intensity of black and/or blue-black tattoos); pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser/light treatment of vascular lesions such as but not limited to, port wine stains, hemangiomas, telangiectasias, rosacea, venous lake, facial and leg veins;

reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar, coagulation and hemostasis of soft tissue; treatment of wrinkles and pseudofolliculitis barbae (PFB).

The Max series Intense Pulsed Light Handpieces are intended for the treatment of inflammatory acne (acne vulgaris) and for the treatment of benign pigmented epidermal and cutaneous lesions, including warts, scars and striae, removal of unwanted hair from skin types I-VI, and to effect stable long-term, or permanent, hair reduction: treatment of benign pigmented lesions, including port wine stains, hemangiomas, aniomas, telangectasias, rosacca, facial and leg veins.

The Skintel Reader is intended as an objective measurement tool for examining skin melanin content for determining and setting a test spot staring fluence.

| | 2940 Fractional Ablative Laser Handpiece<br>(K110907) | 2940 Fraction Ablative Laser Handpiece<br>(Modified) |
|------------|-------------------------------------------------------|------------------------------------------------------|
| Parameter | Description | Description |
| Laser Type | Erbium: YAG (Er:YAG) | Erbium: YAG (Er:YAG) |
| Wavelength | 2940 nm | 2940 nm |

## 807.92(a)(6) Summary of the technological characteristics of the device compared to the predicate

{6}------------------------------------------------

| Fluence<br>(J/cm2) | Optic | Energy<br>(mJ/mB) | Microbeam<br>Density | Pitch (distance<br>between<br>microcolumns) | Optic | Energy<br>(mJ/mB) | Microbeam Density | Pitch (distance<br>between<br>microcolumns) |
|--------------------------------------------|----------------------------------------------------------------------------------------|------------------------|----------------------|---------------------------------------------|----------------------------------------------------------------------------------------|------------------------|-------------------|---------------------------------------------|
| | Silver<br>(Groove<br>тм Optic) | 2-5.5<br>mJ/0.1mm | N/A | 1350 μm<br>(grooves) | Silver<br>(Groove<br>тм Optic) | 2-5.5<br>mJ/0.1mm | N/A | 1350 μm<br>(grooves) |
| | Blue 450<br>Fractional<br>Optic | 3-9 mJ | 469<br>mB/cm² | 450 μm | Blue 450<br>Fractional<br>Optic | 3-9 mJ | 469<br>mB/cm² | 450 μm |
| | Green<br>1200<br>Fractional | 8-24 mJ | 178<br>mB/cm² | 750 μm | Green<br>1200<br>Fractional | 8-24 mJ | 178<br>mB/cm² | 750 μm |
| | Red 140<br>Fractional | 3-9 mJ | 169<br>mB/cm² | 750 μm | Red 140<br>Fractional | 3-9 mJ | 169<br>mB/cm² | 750 μm |
| | Purple<br>Flatbeam | 25 J/cm² –<br>70 J/cm² | N/A | N/A | Purple<br>Flatbeam | 25 J/cm² –<br>70 J/cm² | N/A | N/A |
| Spot Size<br>(mm) and<br>Treatment<br>Zone | 6 x 6 mm and 10 x 10 mm, depending on the Optic Flatbeam:<br>2 mm | | | | 6 x 6 mm and 10 x 10 mm, depending on the Optic<br>Flatbeam: 2 mm | | | |
| Pulse Width<br>(ms) | .25, 3, 5 ms | | | | .25, 3, 5 ms | | | |
| Delivery<br>System | Microbeams of light transmitted via a microlens array in the<br>interchangeable Optic. | | | | Microbeams of light transmitted via a microlens array in<br>the interchangeable Optic. | | | |
| Actuator | Foot pedal | | | | | | | |

### 807.92(b)(1-2) Nonclinical tests submitted

Test

Sterilization Validation

## 807.92(b)(3) Conclusions drawn from non-clinical data

An Autoclave Sterilization Validation of the 10 x 10 and 6 x 6 Focal Guide Assemblies was conducted using Steam Sterilization Validation Procedure. The Focal Guides were originally factory-sterilized by gamma sterilization and the intent is to provide the device to the customer non-sterile, with instructions for on-site autoclave sterilization. The test articles, negative controls, and environmental controls all exhibited no growth G. stearothermophilus after being subjected to 3 half cycle rounds of the gravity cycle settings described in ETR-191, Autoclave Sterilization Validation of 2940 Handpiece Focal Guides, meeting an SAL of ≤10°. The test articles also passed validation of the specified dry time (15 minutes, minimum), as no residual moisture was detected after being subjected to the full gravity cycle settings. Functional testing shows that the sterilization does not affect the function of the device.

{7}------------------------------------------------